Pro-Dex, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PDEX research report →
Companywww.pro-dex.com
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.
- CEO
- Richard Lee Van Kirk Jr.
- IPO
- 1986
- Employees
- 146
- HQ
- Irvine, CA, US
Price Chart
Valuation
- Market Cap
- $202.64M
- P/E
- 16.93
- P/S
- 2.72
- P/B
- 4.50
- EV/EBITDA
- 10.84
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 27.78%
- Op Margin
- 14.48%
- Net Margin
- 16.08%
- ROE
- 29.10%
- ROIC
- 12.33%
Growth & Income
- Revenue
- $66.59M · 23.68%
- Net Income
- $8.98M · 322.10%
- EPS
- $2.73 · 347.54%
- Op Income
- $10.69M
- FCF YoY
- -156.13%
Performance & Tape
- 52W High
- $63.92
- 52W Low
- $23.47
- 50D MA
- $51.73
- 200D MA
- $41.52
- Beta
- -0.11
- Avg Volume
- 26.80K
Get TickerSpark's AI analysis on PDEX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 22, 26 | Domingo Angelita Rebamontan | other | 18 |
| Nov 21, 25 | Philp Katrina Marie Kramer | other | 2,200 |
| Nov 21, 25 | Philp Katrina Marie Kramer | other | 900 |
| Nov 20, 25 | Van Kirk Richard Lee Jr | other | 72 |
| Nov 20, 25 | Swenson Nicholas John | other | 1,000 |
| Nov 20, 25 | Philp Katrina Marie Kramer | other | 1,000 |
| Nov 20, 25 | HOVDA DAVID | other | 1,000 |
| Nov 20, 25 | Farrell William James III | other | 1,000 |
| Nov 20, 25 | Domingo Angelita Rebamontan | other | 1,000 |
| Nov 20, 25 | Domingo Angelita Rebamontan | other | 72 |
Our PDEX Coverage
We haven't published any research on PDEX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PDEX Report →